At Cancer Treatment Centers of America® (CTCA) at Southeastern Regional Medical Center, we focus on fighting complex and advanced stage cancer. To help us accomplish this mission we have cancer-fighting technology that supports our patients fight against this challenging disease.
A few of the most recent additions to the technologies found at Southeastern include the following:
This system combines gating technology, imaging and advanced treatment techniques to treat a variety of cancers anywhere in the body. CTCA at Southeastern Regional Medical Center was the first facility to purchase a TrueBeam® in Georgia. Treatment includes:
The Calypso® 4D Localization System helps our doctors deliver focused doses of radiation with greater accuracy to prostate cancer patients receiving external beam radiation therapy. Also known as GPS for the Body®, this technology allows our radiation therapy team to continuously track movement of the prostate in real time and concentrate radiation to the tumor. By targeting cancer cells and avoiding nearby healthy tissues, Calypso spares the bladder, colon and other critical structures. Learn more about Calypso 4D Localization.
Superficial Hyperthermia is a device used to expose a tumor to high temperatures, making it more susceptible to radiation. It is a support treatment for radiation therapy, and is particularly helpful in treating small tumors not lying deep within the body, such as breast tumors. CTCA at Southeastern Regional Medical Center is the first facility in Georgia offering this service.
This type of imaging uses radiopharmaceuticals to evaluate the anatomy and physiology of the patient. Radiopharmaceuticals are injected, ingested or inhaled, and localize in specific areas of the body. Molecular Imaging procedures can produce images or offer therapeutic treatments, such as I-131 treatment for thyroid cancer.
This is an advanced Nuclear Medicine procedure used to analyze metabolic changes in the body and locate tumors. A radiopharmaceutical tagged to a sugar molecule is injected into the patient, and this material is taken up by active cells. PET can be used throughout the treatment period to determine efficacy and progress. The CT is used to help more specifically locate the activity on the processed images. Having PET/CT available within the same facility as Radiation Oncology optimizes the use of both technologies: the Radiation Oncologist can determine the imaging protocol, to produce information that is more specific and helpful. PET/CT works hand-in-hand with radiation therapy treatment planning.
When patients explore treatment options, they may want to know about issues like life expectancy and quality of life. To help patients and their families make more informed decisions about their cancer treatment, CTCA® publishes our patient survival rates along with quality of life, patient loyalty, and speed of care results.
CTCA® is one of the first cancer treatment centers to provide our results to patients. We believe patients have the right to know this type of information. We also believe in their fundamental right to choose among the best available options for their treatment. To see our statistics and results, please visit Cancer Treatment Statistics & Results.
If you are a previous applicant, please log in below to access your account. Once logged in you can apply to additional positions, update your information, or view your active applications.Click Here